Prof Belkacemi Yazid is currently Chairman of Department of Radiation Oncology, Head of the Henri Mondor Breast Unit, University Hospital Henri Mondor, Creteil, France and Professor in Radiation Oncology, University of Paris XII.
He gained his Medical degree in 1988 and in 1989 he did a Residency in Radiation Oncology in Paris, France. He did a Master in Pharmaco-Oncology in 1991 and in 1992 he specialised in Radiation Oncology followed by a Master in Radiobiology from in 1994 at the Universities of Paris XI and the Institut National des Sciences et Techniques Nucleaires. He gained his PhD as Physical Doctor in 2000 at the University of Paris XI.
Between 1990 and 2002 Prof Belkacemi worked as Radiation Oncologist at the Department of Radiation Oncology, Tenon Hospital, Paris and from 2002 to 2007 at the Department of Radiation Oncology, Anti-cancer center, Oscar Lambret, in Northern France as referent in Breast Cancer. In 2007 he also completed a Master in Medical Management at ESCP-EAP, Paris.
In 2005 he was appointed Associate Professor at the University of Lille II and in 2008 Professor in Radiation Oncology at Creteil Medical School, University of Paris XII.
From 2006 to 2008 Prof Belkacemi worked at the Radiobiology Lab and anti-cancer in Oscar Lambret Center, from 2008 to 2010 as Radiation-Oncologist and vice-chairman of Department of Radiation Oncology, Henri Mondor Hospital, Creteil and until 2011 he was Head of the Department of Radiation Oncology in Princess Grace Hospital, Monaco.
Prof Belkacemi is Member of the ESMO Faculty Group of Principles of Clinical Trials and Systemic Therapy. Furthermore, Prof Belkacemi is founding Member of the Association of Radiotherapy and Oncology of the Mediterranean Area (AROME), he was President of AROME from 2006 to 2011 and currently he is Honorary President and Executive Board member, (AROME). He is Member of the European Society for Therapeutic Radiology and Oncology (ESTRO), Member of the French Society of Radiation Oncology and Member of the French Society of Breast disease, Member of the Radiation Therapy and Breast Groups of the EORTC and Member of the Rare Cancer Network (secretary). He also founded TRONE (TransAtlantic Radiation Oncology network) in 2015.
Prof Belkacemi’s clinical research interests include the management of breast, prostate, haematologic malignancies and rare tumours management and new technologies development in radiation oncology. His biologic research topics are radio-sensitivity markers of tumours and healthy tissues and combinations of targeted therapies and new drugs with ionising radiation.
He is author and co-author of several peer-reviewed publications.